Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sucampo Pharma Inc (SCMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 477,138
  • Shares Outstanding, K 46,550
  • Annual Sales, $ 230,060 K
  • Annual Income, $ 18,490 K
  • 36-Month Beta 1.48
  • Price/Sales 2.03
  • Price/Cash Flow 4.17
  • Price/Book 17.76

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.90 +3.54%
on 08/18/17
11.20 -8.48%
on 08/02/17
-0.60 (-5.53%)
since 07/18/17
3-Month
9.40 +9.04%
on 06/16/17
11.20 -8.48%
on 08/02/17
-0.20 (-1.91%)
since 05/18/17
52-Week
9.30 +10.22%
on 04/18/17
17.55 -41.60%
on 11/30/16
-1.17 (-10.25%)
since 08/18/16

Most Recent Stories

More News
Sucampo Pha-Cl A Down 27.5% Since SmarTrend Downtrend Call (SCMP)

SmarTrend identified a Downtrend for Sucampo Pha-Cl A (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 8 months, Sucampo Pha-Cl A has returned 27.54% as of today's recent price of $10.05....

SCMP : 10.25 (+1.99%)
Sucampo Pha-Cl A Has Returned 25.9% Since SmarTrend Recommendation (SCMP)

SmarTrend identified a Downtrend for Sucampo Pha-Cl A (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 8 months, Sucampo Pha-Cl A has returned 25.92% as of today's recent price of $10.28....

SCMP : 10.25 (+1.99%)
Drug Makers Stock Performance Review -- DURECT, Sucampo Pharma, Apricus Biosciences, and MEI Pharma

If you want a Stock Review on DRRX, SCMP, APRI, or MEIP then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. The profitability of individual companies...

DRRX : 1.63 (-0.61%)
SCMP : 10.25 (+1.99%)
APRI : 1.49 (-0.67%)
MEIP : 2.68 (-2.19%)
Sucampo (SCMP) Q2 Earnings & Revenues Beat Estimates, Up Y/Y

Sucampo Pharmaceuticals' (SCMP) Amitizia recorded strong sales in Japan, which drove the company's top line. The company is also working on expanding its pipeline and Amitizia's label.

AGEN : 3.57 (+1.71%)
MYL : 30.72 (+0.52%)
SCMP : 10.25 (+1.99%)
ARNA : 20.53 (-0.24%)
Investor Network: Sucampo Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 2, 2017 / Sucampo Pharmaceuticals, Inc. Class A (NASDAQ: SCMP) will be discussing their earnings results in their Q2 Earnings Call to be held on Wednesday, August 02,...

SCMP : 10.25 (+1.99%)
Sucampo Pha-Cl A Shares Down 20.2% Since SmarTrend's Sell Call (SCMP)

SmarTrend identified a Downtrend for Sucampo Pha-Cl A (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 7 months, Sucampo Pha-Cl A has returned 20.15% as of today's recent price of $11.08....

SCMP : 10.25 (+1.99%)
Dr. Karen Smith Joins Sucampo's Board of Directors

Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that Karen Smith, M.D., Ph.D., M.B.A., LLM., has joined the Company's Board of Directors on July...

SCMP : 10.25 (+1.99%)
Sucampo Pha-Cl A Down 21.4% Since SmarTrend Downtrend Call (SCMP)

SmarTrend identified a Downtrend for Sucampo Pha-Cl A (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 7 months, Sucampo Pha-Cl A has returned 21.41% as of today's recent price of $10.90....

SCMP : 10.25 (+1.99%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (OMER, SCMP, IPXL, CTLT, SUPN)

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

SCMP : 10.25 (+1.99%)
CTLT : 34.55 (+1.05%)
SUPN : 43.20 (-0.69%)
IPXL : 18.45 (+2.79%)
OMER : 22.03 (-2.00%)
Sucampo (SCMP) Remains Focused on Amitza Label Expansion

We issued an updated report on Sucampo Pharmaceuticals, Inc. (SCMP) on July 4.

ENZ : 10.78 (-2.00%)
MYL : 30.72 (+0.52%)
SCMP : 10.25 (+1.99%)
SNY : 48.19 (+0.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Sucampo Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Sucampo is focused on developing prostones...

See More

Support & Resistance

2nd Resistance Point 10.75
1st Resistance Point 10.50
Last Price 10.25
1st Support Level 9.95
2nd Support Level 9.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.